NYSEAMERICAN:RFLRafael Stock Price, Forecast & News

$17.29

+1.06 (+6.53 %)

(As of 05/29/2020 04:00 PM ET)

Add

Compare

Today's Range

$16.21

Now: $17.29▼

$17.32

50-Day Range N/A

52-Week Range

$9.40

Now: $17.29▼

$30.86

Volume33,933 shs

Average Volume38,476 shs

Market Capitalization$273.49 million

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Rafael Holdings, Inc. holds commercial real estate assets. The company, through its subsidiaries, engages in the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.

Beat the Market (BTM) Rank^™

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Rafael.

2.9 Community Rank

Outperform Votes
Rafael has received 25 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Rafael has received 18 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
Rafael has received 58.14% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about Rafael and other stocks. Vote “Outperform” if you believe RFL will outperform the S&P 500 over the long term. Vote “Underperform” if you believe RFL will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Rafael does not currently pay a dividend.
Dividend Growth
Rafael does not have a long track record of dividend growth.

0.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Rafael insiders have not sold or bought any company stock.

0.0 Earnings and Valuation

Overall Beat the Market Rank^™

0.58 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN

Industry Biotechnology

Sub-IndustryN/A

SectorMedical

Current SymbolNYSEAMERICAN:RFL

Previous Symbol

CUSIPN/A

CIKN/A

Webwww.rafaelholdings.com

Phone212-658-1450

Debt

Debt-to-Equity RatioN/A

Current RatioN/A

Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A

Forward P/E RatioN/A

P/E GrowthN/A

Sales & Book Value

Annual SalesN/A

Price / SalesN/A

Cash FlowN/A

Price / Cash FlowN/A

Book ValueN/A

Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A

Net IncomeN/A

Net MarginsN/A

Return on EquityN/A

Return on AssetsN/A

Miscellaneous

Employees18

Outstanding Shares15,818,000

Market Cap$273.49 million

Next Earnings Date6/3/2020 (Estimated)

OptionableOptionable

Receive RFL News and Ratings via Email

Sign-up to receive the latest news and ratings for RFL and its competitors with MarketBeat's FREE daily newsletter.

Rafael (NYSEAMERICAN:RFL) Frequently Asked Questions

When is Rafael's next earnings date?

Rafael is scheduled to release its next quarterly earnings announcement on Wednesday, June 3rd 2020. View our earnings forecast for Rafael.

How were Rafael's earnings last quarter?

Rafael Holdings Inc (NYSEAMERICAN:RFL) announced its quarterly earnings data on Thursday, March, 5th. The company reported ($0.08) EPS for the quarter. The firm had revenue of $1.24 million for the quarter. View Rafael's earnings history.

Has Rafael been receiving favorable news coverage?

Press coverage about RFL stock has been trending very negative recently, InfoTrie reports. The research firm identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Rafael earned a coverage optimism score of -3.7 on InfoTrie's scale. They also assigned press coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutRafael.

Who are some of Rafael's key competitors?

Some companies that are related to Rafael include PureTech Health (PRTC), Bellus Health (BLU), CEL-SCI (CVM), Oxford BioMedica (OXB), Cel-Sci (CVM), SIGA Technologies (SIGA), Paradigm Biopharmaceuticals (PAR), Biotest (BIO), Neptune Wellness Solutions (NEPT), Silence Therapeutics (SLN), TELIX Pharmaceutical (TLX), Starpharma (SPL), Medicenna Therapeutics (MDNA), ProMetic Life Sciences (PLI) and IMV (IMV). View all competitors.

What other stocks do shareholders of Rafael own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Rafael investors own include AbbVie (ABBV), Bank of Nova Scotia (BNS), Gilead Sciences (GILD), Harley-Davidson (HOG), Altria Group (MO), Pfizer (PFE), Verizon Communications (VZ), Algonquin Power & Utilities (AQN), Axonics Modulation Technologies (AXNX) and BCE (BCE).

Who are Rafael's key executives?

Rafael's management team includes the following people:

Mr. Howard S. Jonas, Chairman & CEO (Age 63)
Mr. Menachem Ash, Pres & Gen. Counsel (Age 47)
Mr. David A. Polinsky, Chief Financial Officer (Age 47)
Ms. Joyce J. Mason Esq., Corp. Sec. (Age 60)

What is Rafael's stock symbol?

Rafael trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "RFL."

Who are Rafael's major shareholders?

Rafael's stock is owned by many different retail and institutional investors. Top institutional shareholders include BlackRock Inc. (4.64%), Kahn Brothers Group Inc. DE (2.71%), State Street Corp (1.18%), Geode Capital Management LLC (0.93%), Soleus Capital Management L.P. (0.56%) and Nuveen Asset Management LLC (0.28%).

Which institutional investors are selling Rafael stock?

RFL stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, UBS Group AG, Kahn Brothers Group Inc. DE, and Wells Fargo & Company MN.

Which institutional investors are buying Rafael stock?

RFL stock was acquired by a variety of institutional investors in the last quarter, including Soleus Capital Management L.P., BlackRock Inc., Geode Capital Management LLC, Nuveen Asset Management LLC, PNC Financial Services Group Inc., State Street Corp, Bank of New York Mellon Corp, and Rhumbline Advisers.

How do I buy shares of Rafael?

Shares of RFL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Rafael's stock price today?

One share of RFL stock can currently be purchased for approximately $17.29.

How big of a company is Rafael?

Rafael has a market capitalization of $273.49 million. Rafael employs 18 workers across the globe.

What is Rafael's official website?

The official website for Rafael is www.rafaelholdings.com.

How can I contact Rafael?

The company can be reached via phone at 212-658-1450.

This page was last updated on 5/30/2020 by MarketBeat.com Staff